Cargando…
Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 Gene mutation
Autores principales: | Kim, Yoo-Mi, Choi, Jin-Ho, Lee, Beom Hee, Jung, Chang-Woo, Jin, Hye Young, Kim, Jae-Min, Kim, Gu-Hwan, Hwang, Jin Soon, Yang, Sei Won, Lee, Jin, Yoo, Han-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850151/ http://dx.doi.org/10.1186/1687-9856-2013-S1-P51 |
Ejemplares similares
-
Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
por: Jeong, Insook, et al.
Publicado: (2016) -
KRAS Analysis in 34 Noonan Syndrome Patients without
PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007) -
Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
por: Jo, Kyo Jin, et al.
Publicado: (2019) -
Noonan syndrome: rhGH treatment and
PTPN11
mutation
por: Wu, Xian, et al.
Publicado: (2023) -
Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
por: Jorge, Alexander A L, et al.
Publicado: (2022)